Bellerophon Therapeutics, Inc.·4

Jun 30, 6:44 PM ET

Bellerophon Therapeutics, Inc. 4

4 · Bellerophon Therapeutics, Inc. · Filed Jun 30, 2017

Insider Transaction Report

Form 4
Period: 2017-06-28
Luehring Jens
Director10% Owner
Transactions
  • Award

    Common Stock

    2017-06-28+30,79870,658 total

Documents

1 file
  • 4
    wf-form4_149886262686504.xmlPrimary

    FORM 4